Researchers are developing an implantable sensor for glaucoma that allows intraocular pressure to be read by a smartphone camera. Diagnosis and monitoring now relies on a trip to the ophthalmologist and a reading of intraocular pressure that can vary widely. The implant/smartphone combination is expected to allow at-home monitoring and a series of readings that could improve diagnosis and monitoring of glaucoma patients.
Medical students at Standford are joining the ranks of future surgeons learning how to use Google Glass as an operation tool.
Stanford University is partnering with Plantation, FL-based Neurotrope to study a class of compounds called bryostatins with the aim of developing potential clinical candidates for the treatment of various neurological disorders.
Stanford University electrical engineer Ada Poon has developed a method of powering tiny medical implants such as pacemakers located deep inside the body, potentially paving the way forward for the development of electroceuticals as an alternative, or even replacement, to pharmaceuticals.
The FDA is setting up its first West Coast Center of Excellence in Regulatory Science and Innovation (CERSI) to further strengthen ties with academia and improve its use of informatics and data-driven computer models. The University of California, San Francisco, is housing the CERSI, which it will run in collaboration with scientists at Stanford University.
The FDA has selected Johns Hopkins University, Stanford University and the University of California, San Francisco, for a new initiative aimed at streamlining the drug development and approval process.
Academic research institutions play a crucial role in the drug development process, especially on the preclinical research and drug discovery side, as Big Pharma companies are increasingly cutting back their R&D spending. We've taken a look at some of the best research institutions in the U.S. and ranked by them by their level of funding from the National Institutes of Health, the largest funder of biomedical research in the world.
Illumina is a company that has become used to success. Yet this week a collaboration between Illumina and The Scripps Research Institute lost to a Stanford University-led academic consortium in a bid for a $40 million grant to set up a stem cell genomics center in California.
Memorial Sloan-Kettering Cancer Center in New York now has an extra $90 million to devote to cancer immunotherapy research.
Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...